LivaNova, a market-leading medical technology and innovation company, will present an ePoster at the European Society of Cardiology (ESC) Congress 2020 on the potential for autonomic regulation therapy (ART) via… Read More
SAN DIEGO, Aug. 26, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that Saiid Zarrabian, Chief Executive Officer of Kintara,… Read More
SAN DIEGO, Aug. 25, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that it has closed its previously announced private placement with investors providing for… Read More
Vancouver, British Columbia – August 24, 2020 – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function,… Read More
SAN DIEGO, Aug. 21, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharmaceuticals, Inc.) (“Kintara” or the “Company”) (Nasdaq: KTRA) announced today that it has regained compliance with the minimum bid… Read More
